Skip to main content
Livermore
Livermore
ZHEN

Profund Advisors LLC

SEC CIK
0001129919
Latest filing
Aug 11, 2026

GSK holding history

GSK plc in every 13F filed by Profund Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
13,076
Value
$685.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by Profund Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613,076$685.4K<0.1%−377−2.8%ReducedHolders
Q1 202613,453$742.5K<0.1%−2,093−13.5%ReducedHolders
Q4 202515,546$762.4K<0.1%+360+2.4%AddedHolders
Q3 202515,186$655.4K<0.1%−3,726−19.7%ReducedHolders
Q2 202518,912$726.2K<0.1%+652+3.6%AddedHolders
Q1 202518,260$707.4K<0.1%+6,372+53.6%AddedHolders
Q4 202411,888$402.1K<0.1%−1,129−8.7%ReducedHolders
Q3 202413,017$532.1K<0.1%−1,962−13.1%ReducedHolders
Q2 202414,979$576.7K<0.1%+433+3.0%AddedHolders
Q1 202414,546$623.6K<0.1%−2,038−12.3%ReducedHolders
Q4 202316,584$614.6K<0.1%+7,149+75.8%AddedHolders
Q3 20239,435$342.0K<0.1%−558−5.6%ReducedHolders
Q2 20239,993$356.2K<0.1%−1,912−16.1%ReducedHolders
Q1 202311,905$423.6K<0.1%+908+8.3%AddedHolders
Q4 202210,997$386.4K<0.1%−2,226−16.8%ReducedHolders
Q3 202213,223$389.0K<0.1%−5,211−28.3%ReducedHolders
Q2 202218,434$802.0K0.1%−2,040−10.0%ReducedHolders
Q1 202220,474$892.0K<0.1%+1,885+10.1%AddedHolders
Q4 202118,589$820.0K<0.1%+1,157+6.6%AddedHolders
Q3 202117,432$666.0K<0.1%+726+4.3%AddedHolders
Q2 202116,706$666.0K<0.1%+446+2.7%AddedHolders
Q1 202116,260$580.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.